From: Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer
Response
Number
Evidence of progression
Time to progression Median (months)
Number deceased
Complete
9
17
6
Partial
7
8
Stable
3
Progressive
1